Key result
Nonpharmaceutical interventions for COVID-19 were associated with a decrease in human enterovirus detection among children with HFMD or HA, dropping from 5.63% pre-pandemic to 1.19% in 2020.
Why the study?
Nonpharmaceutical interventions for COVID-19 influence the transmission of other viruses, prompting investigation into their impact on human enterovirus infection in children with HFMD or herpangina.
Do nonpharmaceutical interventions for COVID-19 reduce the transmission of human enterovirus in children with HFMD or HA?
Observational (n=41,742)
Do nonpharmaceutical interventions for COVID-19 reduce the transmission of human enterovirus in children with HFMD or HA?
Absolute Event Rate: 1.19% vs 5.63%
Nonpharmaceutical interventions for COVID-19 were associated with a significant reduction in enterovirus transmission among children, which rebounded after interventions were relaxed.
No takes yet. Share an insight, caveat, or question.
NPIs may reduce pediatric HEV infections; leaves open whether targeted measures warrant adoption beyond pandemic settings.
Sun et al. (2024) conducted an observational in Hand, foot, and mouth disease (HFMD) or herpangina (HA) (n=41,742). Nonpharmaceutical interventions (NPIs) for COVID-19 vs. Pre-COVID-19 period was evaluated on Human enterovirus (HEV) infection detection rate. Nonpharmaceutical interventions for COVID-19 were associated with a decrease in human enterovirus detection among children with HFMD or HA, dropping from 5.63% pre-pandemic to 1.19% in 2020.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: